{
    "clinical_study": {
        "@rank": "53839", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if nimodipine is more effective than placebo in\n      reducing stimulated craving for cocaine in cocaine dependent individuals denied access to\n      cocaine in inpatient unit."
        }, 
        "brief_title": "High Dose Nimodipine Treatment Adjunct - 1", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": "0", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000332", 
            "org_study_id": "NIDA-3-0009-1", 
            "secondary_id": "Y01-3-0009-1"
        }, 
        "intervention": {
            "intervention_name": "Nimodipine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Nimodipine"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Washington", 
                    "country": "United States", 
                    "state": "District of Columbia", 
                    "zip": "20422"
                }, 
                "name": "Washington DC VA"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "High Dose Nimodipine Pharmacotherapy Adjunct", 
        "overall_official": {
            "affiliation": "Washington DC VA", 
            "last_name": "Steven Deutsch, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Stimulated and non-stimulated craving"
            }, 
            {
                "measure": "Stimulated and non-stimulated withdrawal"
            }, 
            {
                "measure": "Anxiety, depression"
            }, 
            {
                "measure": "Heart rate"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000332"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "Washington DC VA": "38.895 -77.036"
    }
}